START: Cost-utility Analysis of Ambulatory Care Compared to Conventional Patient Care of Permanent Pacemakers Replacement for Elective Replacement Indicator

Sponsor
Nantes University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03876600
Collaborator
Ministry of Health, France (Other)
750
14
2
36
53.6
1.5

Study Details

Study Description

Brief Summary

START study is a comparison of cost-utility between permanent pacemaker replacement ambulatory care and permanent pacemaker replacement conventional hospitalization care.

The hypothesis of the study is that ambulatory care compared to conventional hospitalization, involving a stay of more than 24 hours, would reduce hospitalization and care expenses without loss of quality of care and without increasing the complication rate for patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Replacement of permanent pacemakers for elective wear.
N/A

Detailed Description

In France, nearly 49,000 permanent pacemakers are implanted each year. The pacemaker longevity is about 10 years which leads to their replacement.

In France, in 2016, 15,764 pacemaker replacement hospital stays took place. 10.6% of them were made during an outpatient stay, 12.4% during a one-night hospitalization and 70.7% during hospitalization for two or more than two nights for the severity level 1.

If the outpatient care management is deployed at 90%, the economy of the cost care will be estimated to be 3,5 million euros and a reduction of 15 582 hospitalization night's stay.

The aim of START study is to compare cost-utility between ambulatory and conventional hospitalization care of permanent pacemakers replacement for elective replacement indicator and to demonstrate equivalence between outpatient management and conventional hospitalization management.

This study is in adequation with the national ambition to deploy the outpatient management in France. Surgery is the same with both hospitalization managements.

An ambulatory surgery need to present different advantages and benefits like high quality care and substantial cost savings.

The benefits of ambulatory care management are :
  • An economy of hospitalization nights cost.

  • A decrease in health costs related to the surgery realization.

  • Patient satisfaction expected due to hospital discharged within 24 hours. Patient is expected to go home the same day as the surgery with good perception of ambulatory surgery.

  • A decrease in the disorientation risk in the elderly patient is also expected.

Surgery is the same with both hospitalization managements.

Patients will be randomized in 2 arms. An arm conventional hospitalization management (control arm) and an arm outpatient care management.

Study period is 30 months. Patients will be following during 6 months. The recruitment time will be 24 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
750 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Cost-utility Analysis of Ambulatory Care Compared to Conventional Patient Care of Permanent Pacemakers Replacement for Elective Replacement Indicator
Anticipated Study Start Date :
Apr 1, 2019
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: conventional hospitalization management.

The patients who are randomized to have a conventional hospitalization for the pacemaker replacement have conventional management. In this management patient come to hospital one day before this surgical operation and he is operated next day

Procedure: Replacement of permanent pacemakers for elective wear.
START's intervention is a replacement of permanent pacemakers for elective wear, for the both arms the surgical intervention is the same. The surgical procedure is the same in the both arms. The differences are in conventional hospitalization, patient comes to hospital one day before operation and he can go out one day after operation. In ambulatory patient come to hospital operation days and he can got out the same day.

Active Comparator: ambulatory management

The patients who are randomized to have a ambulatory surgery for the pacemaker replacement have ambulatory management. In the ambulatory hospitalization patients come to hospital and have a surgical operation the same day

Procedure: Replacement of permanent pacemakers for elective wear.
START's intervention is a replacement of permanent pacemakers for elective wear, for the both arms the surgical intervention is the same. The surgical procedure is the same in the both arms. The differences are in conventional hospitalization, patient comes to hospital one day before operation and he can go out one day after operation. In ambulatory patient come to hospital operation days and he can got out the same day.

Outcome Measures

Primary Outcome Measures

  1. Cost-utility analysis,from the perspective of the society and a time horizon of 6 months,of ambulatory management compared to the intervention in conventional hospitalization of a replacement,for elective wear,permanent pacemakers [6 month]

    Incremental cost-utility ratio (cost by quality-adjusted life-years, QALY) of outpatient management compared to compared to the intervention in conventional hospitalization (≥1 night) of a replacement, for elective wear, permanent pacemakers. This analysis is from the perspective of the society and a time horizon of 6 months.

Secondary Outcome Measures

  1. Assess, the point of view of health insurance and health care institutions with a time horizon of 5 years, the annual and global budgetary impact in € of different diffusion scenarios for ambulatory to replace conventional hospitalization [on a time horizon of 5 years]

    Annual and global net profit cost in € of different diffusion scenarios for ambulatory to replace conventional hospitalization.

  2. Evaluate and compare the rate of complications of different management within 6 months after the intervention in both arms. [on time horizon of 6 months]

    Complication statement requiring a rehospitalization with reoperation. This objective is assessed by the complication statement requiring rehospitalization without reoperation and complication with not requiring rehospitalization.

  3. Evaluate the ambulatory failure rate [during all the study, during 30 months.]

    Ambulatory failure rate. It is a ratio of the number of ambulatory visits converted to conventional hospitalization and the total number of ambulatory visits.

  4. Evaluate and compare patients satisfaction between intervention and hospital management in both arms [during hospitalization, during 2 days]

    Satisfaction with the intervention and management at the hospital with questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Man or woman over 18 years old.

  • Replacement of permanent pacemakers for battery elective wear without programmed act in the sensors regardless of pacemaker type, simple, dual or triple chambers and regardless pacemaker label.

  • Patient living less than an hour from a hospital center

  • Patient is able to answer the phone.

  • Patient has an accompaniment the go out night

  • Pacemaker-dependent patient or not regardless of indication of placement of the pacemaker

  • Patient with or without anticoagulant treatment: the anticoagulant treatment is managed by center under these habits.

  • Patient has given this free and informed consent.

  • Patient having insurance in France.

Exclusion Criteria:
  • Ambulatory Hospitalization is impossible.

  • Patient refuses to participate

  • Patient has hemostasis disorder yielding ambulatory hospitalization impossible.

  • Woman is pregnant, nursing mothers or the patient don't receive an effective contraception.

  • Patient under guardianship, safeguard of justice

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lyon University Hospital Lyon Bron France 69677
2 Angers University Hospital Angers France 49933
3 Brest University Hospital Brest France 29200
4 Dijon University Hospital Dijon France 21079
5 Grenoble University Hospital Grenoble France 38000
6 AP-HM Marseille France 13005
7 Montpellier University Hospital Montpellier France 34295
8 Nancy University Hospital Nancy France 54511
9 AP-HP, La Pitié Salpétrière Paris France 75013
10 Rennes University Hospital Rennes France 35033
11 Saint-Etienne University Hospital Saint-Étienne France 42100
12 Strasbourg University Hospital Strasbourg France
13 Toulouse University Hospital Toulouse France 31059
14 Tours University Hopsital Tours France 37044

Sponsors and Collaborators

  • Nantes University Hospital
  • Ministry of Health, France

Investigators

  • Principal Investigator: Vincent Probst, Nantes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT03876600
Other Study ID Numbers:
  • RC18_0034
First Posted:
Mar 15, 2019
Last Update Posted:
Mar 15, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nantes University Hospital

Study Results

No Results Posted as of Mar 15, 2019